Oxford vaccine update: Serum Institute’s name recommended for phase 2, 3 human trials of COVID-19 vaccine candidate

Oxford vaccine update: The first two-phase trials of Covishield COVID-19 vaccine conducted in the UK have shown that it has an acceptable safety profile and homologous boosting increased antibody responses.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...